Can Respiratory Rate Predict the Risk of Deterioration of Septic Patients
The primary objective is to determine if the trend in Respiratory Rate measurements provided by the device under investigation can be used to predict an increase in Sequential/Sepsis-related Organ Failure Assessment (SOFA) score.
The RR trend will be measured as the difference between the RR recorded by the device at a point 15 minutes after commencement of treatment, as per the standard of care for patients suspected of being septic, and a point 3 hours following this.
調査の概要
状態
条件
詳細な説明
The primary objective is to determine if the trend in Respiratory Rate measurements provided by the device under investigation can be used to predict an increase in Sequential/Sepsis-related Organ Failure Assessment (SOFA) score.
The RR trend will be measured as the difference between the RR recorded by the device at a point 15 minutes after commencement of treatment, as per the standard of care for patients suspected of being septic, and a point 3 hours following this.
Secondary objective The secondary objective is to test if Respiratory Rate can help identify patients at increased risk of 30 day mortality.
The null Hypotheses of the planned comparison is that there is no difference in the RR trend in the 3 hours following commencement of treatment for sepsis in subjects who have an increase in SOFA score by 2 or more points and those who have a change in SOFA score of +1 or less.
The change in SOFA score will be measured at point of commencement of treatment and at 6 hours following commencement of treatment, or nearest available SOFA score determination.
Respiratory Rate captured during admission could have a predictive course for cohort of interest
The time points for reviewing the RR will be as follows:
(i) The last measurement (ii) The trend over 3 hours following commencement of treatment as per the standard of care for patients suspected of being septic.
(iii) The trend over the entire duration of admission
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
South West Jutland
-
Esbjerg、South West Jutland、デンマーク、DK-6700
- Hospital of South West Jutland, Department of Emergency Medicine
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
Inclusion criteria
- ≥ 18 Years
- Admitted for a minimum of 12 hours
- Have been diagnosed with sepsis
Sepsis diagnosis confirmed by documented or suspected infection (ordering of blood culture or other microbiological investigation by the clinician) and ≥1 of the following presenting within the first 4 hours of admission:
- Fever or hypothermia, Core temperature > 38.3 or < 36 °C
- Heart rate > 90/min
- Respiratory rate > 20/min
- Altered consciousness/mental state, defined as GCS < 15
- Hyperglycemia, (BS > 6.7 mmol/L non-diabetic)
- LKC > 12 *10^9 or < 4*10^9,
- Normal LKC with > 10 % immature cells,
- CRP > highest normal local lab. Interval
- Hypotension: Systolic BP <90 mmHg, or drop in systolic BP > 40
- Hypoxemia: PaO2 < 8.5 Kpa or PaO2/FiO2 < 40 or tissue perfusion: P-lactate > 1.6
- Creatinine . 177 µmol/L
- Acute oliguria (Diuresis per hour ,0.5 ml/kg/t or 45 ml/t in 2 hours)
- Coagulopathy: Spontaneous INR > 1.5, or apt > 60 sec, thrombocytopenia
- Paralytic ileus (absence of bowel sounds)
- Hyperbilirubinemia > 34µmol/L
- Are willing to voluntarily sign a statement of informed consent to participate in this investigation
Exclusion criteria
- Allergic to medical grade skin adhesive
- Pregnant women during second and third trimester
- Continuous long term steroid use. Defined as not using steroids in the 4 weeks previous to enrolment
- Patients under the influence of substance abuse (drug or alcohol) that may interfere with their ability to cooperate and comply with the investigation procedures
- Any disorder, including cognitive dysfunction, which would affect the ability to accurately complete questionnaires and freely give full informed consent. This will be determined by the Abbreviated Mental Test Score (AMT) Cannot be followed a second time if admitted again at a later date during the study period
研究計画
研究はどのように設計されていますか？
デザインの詳細
コホートと介入
グループ/コホート |
|---|
|
Suspicion of Sepsis
Patients who are admitted and are diagnosed with sepsis will be recruited for this investigation.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
RespiraSense triggered escalation in SOFA score
時間枠：15 minutes after commencement of treatment, as per the standard of care for patients suspected of being septic, and a point 3 hours following this.
|
Escalation of SOFA score by 2 or more points.
The primary endpoint will be evaluated with an ANCOVA with escalation of SOFA score by 2 or more points as a factor and mean RR in the first hour of treatment as a covariate.
|
15 minutes after commencement of treatment, as per the standard of care for patients suspected of being septic, and a point 3 hours following this.
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Upward trend in Respiratory Rate as a predictor of 30 day mortality
時間枠：30 days after discharge
|
The secondary endpoint is the 30 day mortality rate after discharge.
|
30 days after discharge
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Upward trend in Respiratory Rate as a predictor of 30 day readmission.
時間枠：30 days after discharge
|
The secondary endpoint is the 30 day readmission rate after discharge.
|
30 days after discharge
|
協力者と研究者
スポンサー
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- PMD-CS-006ii
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。